Limited Immune-Modulating Activity of Porcine Mesenchymal Stromal Cells Abolishes Their Protective Efficacy in Acute Kidney Injury

被引:21
作者
Brunswig-Spickenheier, Baerbel
Boche, Janna
Westenfelder, Christof [3 ]
Peimann, Frauke
Gruber, Achim D. [4 ]
Jaquet, Kai [5 ]
Krause, Korff [5 ]
Zustin, Jozef [2 ]
Zander, Axel R.
Lange, Claudia [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Osteopathol, D-20246 Hamburg, Germany
[3] Univ Utah, George E Wahlen Vet Affairs Med Ctr, Sect Nephrol N 111, Salt Lake City, UT USA
[4] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, D-1000 Berlin, Germany
[5] Asklepios Clin St Georg, Dept Cardiol, Hamburg, Germany
关键词
ACUTE-RENAL-FAILURE; STEM-CELLS; T-CELL; EPITHELIAL-CELLS; ISCHEMIA; REPAIR; RECOVERY; DIFFERENTIATION; TRANSPLANTATION; SIGNALS;
D O I
10.1089/scd.2009.0494
中图分类号
Q813 [细胞工程];
学科分类号
摘要
We demonstrated previously that administration of mesenchymal stromal cells (MSCs) after renal ischemia/reperfusion injury (IRI) in rats protected renal function and hastened repair through complex paracrine mechanisms. Here we investigated kidney-protective actions of MSCs in a porcine IRI model that may have relevance to human acute kidney injury (AKI). Groups of female pigs with bilateral IRI were infused with autologous or male allogeneic MSCs. No acute or late complications were observed, but unexpectedly, MSC therapy also had no beneficial effects on kidney function and histology. In vitro, we demonstrated substantial functional and phenotypic overlaps between rodent, human, and porcine MSCs, all of which exhibited trilineage differentiation, characteristic antigen profiles, and secretion of renoprotective vascular endothelial growth factor (VEGF)-A and insulin-like growth factor-1 (IGF-1). However, in striking contrast to human MSCs, porcine MSCs failed to inhibit the mixed lymphocyte reaction (MLR) and induced robust production of proinflammatory interleukin-6 (IL-6). In summary, in contrast to rodent models, treatment of porcine IRI with MSCs was not kidney-protective. This, we conclude, is due to the fact that porcine MSCs exert inadequate immune-modulating effects, further demonstrating that successful therapy of IRI with MSCs critically depends on their anti-inflammatory actions. As a consequence, treatment of AKI with MSCs is not informative regarding the investigation of the underlying mechanisms in this large animal model. We expect, however, that the treatment of human IRI of the kidney with immune-modulating MSCs will be as effective as in rodent models.
引用
收藏
页码:719 / 729
页数:11
相关论文
共 50 条
[21]   In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury:: Detection and monitoring at 3T [J].
Ittrich, Harald ;
Lange, Claudia ;
Toegel, Florian ;
Zander, Axel R. ;
Dahnke, Hannes ;
Westenfelder, Christof ;
Adam, Gerhard ;
Nolte-Ernsting, Claus .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 25 (06) :1179-1191
[22]   Mesenchymal stem cells:: heading into the clinic [J].
Koç, ON ;
Lazarus, HM .
BONE MARROW TRANSPLANTATION, 2001, 27 (03) :235-239
[23]   Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes [J].
Kunter, Uta ;
Rong, Song ;
Boor, Peter ;
Eitner, Frank ;
Mueller-Newen, Gerhard ;
Djuric, Zivka ;
van Roeyen, Claudia R. ;
Konieczny, Andrzej ;
Ostendorf, Tammo ;
Villa, Luigi ;
Milovanceva-Popovska, Maja ;
Kerjaschki, Dontscho ;
Floege, Juergen .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06) :1754-1764
[24]   Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis [J].
Kunter, Uta ;
Rong, Song ;
Djuric, Zivka ;
Boor, Peter ;
Muller-Newen, Gerhard ;
Yu, Donghai ;
Floege, Jurgen .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2202-2212
[25]   Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats [J].
Lange, C ;
Tögel, F ;
Ittrich, H ;
Clayton, F ;
Nolte-Ernsting, C ;
Zander, AR ;
Westenfelder, C .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1613-1617
[26]   High-potential human mesenchymal stem cells [J].
Lange, C ;
Schroeder, J ;
Lioznov, MV ;
Zander, AR .
STEM CELLS AND DEVELOPMENT, 2005, 14 (01) :70-80
[27]   Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transniantation and regenerative medicine [J].
Lange, Claudia ;
Cakiroglu, Figen ;
Spiess, Andrej-Nikolai ;
Cappallo-Obermann, Heike ;
Dierlamm, Judith ;
Zander, Axel R. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (01) :18-26
[28]   Immunomodulation by mesenchymal stem cells and clinical experience [J].
Le Blanc, K. ;
Ringden, O. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (05) :509-525
[29]   Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study [J].
LeBlanc, Katarina ;
Frassoni, Francesco ;
Ball, Lynne ;
Locatelli, Franco ;
Roelofs, Helene ;
Lewis, Ian ;
Lanino, Edoardo ;
Sundberg, Berit ;
Bernardo, Maria Ester ;
Remberger, Mats ;
Dini, Giorgio ;
Egeler, R. Maarten ;
Bacigalupo, Andrea ;
Fibbe, Willem ;
Ringden, Olle .
LANCET, 2008, 371 (9624) :1579-1586
[30]   Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6 [J].
Lee, Ryang Hwa ;
Pulin, Andrey A. ;
Seo, Min Jeong ;
Kota, Daniel J. ;
Ylostalo, Joni ;
Larson, Benjamin L. ;
Semprun-Prieto, Laura ;
Delafontaine, Patrice ;
Prockop, Darwin J. .
CELL STEM CELL, 2009, 5 (01) :54-63